Amarchand helps Fresenius Kabi sell 15 stake in Oncology business

Singapore based Fresenius Kabi is planning to sell 15 per cent stake in it’s Indian subsidiary Fresenius Kabi Oncology through stock exchanges in one or more tranches in order to increase the public shareholding of the company.